Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)
In 2018, the World Health Organization (WHO) established the Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) to act as an advisory body
to matters of global policies and strategies related to in vitro diagnostics (IVDs). The SAGE IVD is expected to meet every two years to make recommendations on the content, format, and implementation of the WHO model list of essential in vitro diagnostics (EDL) and on any matters related to IVDs.
Declarations of Interests
WHO Secretariat has received and assessed all the DOIs submitted by the participating experts. In accordance with WHO's policy, all declared interests, even if they do not give rise to a conflict of interest that would warrant partial or total exclusion of the expert concerned, will be disclosed within the Committee at the beginning of the meeting so that other members are aware of them.
Calls
SAGE IVD terms of reference
27 March 2023
2023 Terms of Reference for Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)
The document describes the application process, roles and expectations of the members of SAGE IVD. This is a revised version as of March 2023. This version...
28 January 2021
2021 Terms of Reference for Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)
The document describes the application process, roles and expectations of the members of SAGE IVD. This is a revised version as of December 2020. This...
6 June 2018
2018-2020 Terms of Reference for Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD)
The following describes the application process, roles and expectations of the members of SAGE IVD. This is a revised version as of June 2018. This version...
2023 SAGE IVD panel
Dr Kenneth Anthony Fleming
Lead of the Lancet Commission on Diagnosis
Dr Itsuki Hamamoto
Researcher at the National Institute of Infectious Diseases
Dr Runa Jha
Director of the National Public Health Laboratory of Nepal
Daniel Mukadi-Bamuleka
Director of BSL-3/BSL-2 Rodolphe Mérieux INRB-Goma
Professor Christophe Peyrefitte
Director of the Institut Pasteur de Guyane
Prof Sadia Shakoor
Associate Professor of clinical microbiology
Professor Mandira Varma Basil
Professor of Medical Microbiology at Vallabhbhai Patel Chest Institute, University of Delhi
Dr Lyu Yunfeng
Researcher at Center for Medical Device Evaluation NMPA
Prof Patricia García
Professor School of Public Health at Cayetano Heredia University
Dr Amina Hançali
Head of the National Reference laboratory on STI at the National Institute of Hygiene
Professor François-Xavier Mbopi Keou
Chair of the Department of Microbiology/Parasitology, Haematology, Immunology and Infectious Diseases at the University of Yaoundé I
Mr Paulinus Nnamdi Offutalu
Laboratory Manager, MLSCN-IVD Laboratory
Prof William Sewell
Immunopathologist in St Vincent’s Hospital
Dr Dario Trapani
Medical oncologist
Dr Michael Wilson
Professor of Pathology at the University of Colorado School of Medicine and Director of the Department of Pathology and Laboratory Services at Denver Health
Previous SAGE IVD panels
2021 SAGE IVD panel
2018 SAGE IVD panel
2020 SAGE IVD panel
2019 SAGE IVD panel
Publications
All →
14 June 2021
Technical specifications for selection of essential in vitro diagnostics for SARS-CoV-2
NOTE: This publication is under review and a new version will be published during the third quarter of 2022. Technical specifications for in vitro diagnostics...
Report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (including the third WHO model list of essential...
18 September 2020
The selection and use of essential in vitro diagnostics: WHO technical report series;1022
The report of the second meeting of the Strategic Advisory Group of Experts on In Vitro was launched in November 2019 and includes the updated WHO Model...
20 November 2019
Second WHO Model List of Essential In Vitro Diagnostics
This document is intended to provide a convenient reference to the second edition of the WHO Model List of Essential In Vitro diagnostics (EDL). The EDL...
29 March 2019
First WHO model list of essential in vitro diagnostics
The three strategic priorities of WHO stated in its Thirteenth General Programme of Work 2019–2023 are to advance universal health coverage, address...